Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Renovaro Inc. is a biotechnology company focused on developing advanced cell and gene therapies for cancer and infectious diseases, aiming for long-term remission and cures. Its subsidiaries, Renovaro Biosciences and Renovaro Cube, leverage proprietary AI and multi-omics platforms for early cancer detection, recurrence monitoring, and personalized diagnostics. The company combines innovative therapeutics with precision diagnostics to improve patient outcomes and reduce healthcare costs.
This description was generated via AI from an annual report. Updated about 1 year ago.